NVX-207

Products

Inquiry

Cat. No.: IBDI-434912

NVX-207, a Betulinic acid-derived anti-cancer compound, shows anti-tumor activity (mean IC50=3.5 μM) against various human and canine cell lines. NVX-207-induced apoptosis is associated with activation of the intrinsic apoptotic pathway via cleavage of caspases -9, -3, -7 and of PARP.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target	Apoptosis
Molecular Weight	601.86
Appearance	Solid
SMILES	O=C([[email protected]]1(CC[[email protected]]2C(C)=C)[[email protected]@]2([H])[[email protected]](CC[[email protected]@]3([H])[[email protected]]4(CC[[email protected]]5([H])[[email protected]@]3(CC[[email protected]](OC(C)=O)C5(C)C)C)C)([H])[[email protected]@]4(C)CC1)OCC(CO)(N)CO
Purity	≥98.0%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Powder: -20°C/3 years; 4°C/2 years In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.